Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas...

by A. López-Pousa, J. Martín, J. Montalar, R. de las Peñas, J. García del Muro, J. Cruz, J. Maurel, P. Escudero, A. Casado, J. M. Buesa, the Spanish Group for Research on Sarcomas (GEIS)
Published 2006-01-01

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas:...

by A. Poveda, A. López-Pousa, J. Martín, J. García Del Muro, R. Bernabé, A. Casado, C. Balañá, O. Sanmartín, M. D. Menéndez, P. Escudero, J. Cruz, Elena Belyakova, D. Menéndez, J. M. Buesa
Published 2005-01-01

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial

by Estela Pineda, A Salud, E Vila-Navarro, MJ Safont, Beatriz Llorente, J Aparicio, R Vera, P Escudero, E Casado, C Bosch, U Bohn, R Pérez-Carrión, A Carmona, JR Ayuso, T Ripollés, R Bouzas, M Gironella, X García-Albéniz, J Feliu, J Maurel
Published 2017-05-01